OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
6
Results
Show all
Save search
Copy query
Show results for
Unknown
(6)
Publication Date
Release Date
2025
(2)
2021
(2)
2024
(1)
2020
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Efficacy and Safety of Obinutuzumab in Immune-Mediated Thrombotic Thrombocytopenic Purpura.
Not available
S-EPMC11705199
|
biostudies-literature
Cite
Six-month antibody response to SARS-CoV-2 in healthcare workers assessed by virus neutralization and commercial assays.
Not available
S-EPMC7803622
|
biostudies-literature
Cite
Anti-ADAMTS13 Antibodies Trajectory is Associated With ADAMTS13 Recovery in Immune-Mediated TTP.
Not available
S-EPMC12417756
|
biostudies-literature
Cite
Assessment of serological techniques for screening patients for COVID-19 (COVID-SER): a prospective, multicentric study.
Not available
S-EPMC7688438
|
biostudies-literature
Cite
Risk factors for early mortality from lung cancer: evolution over the last 20 years in the French nationwide KBP cohorts.
Not available
S-EPMC11214995
|
biostudies-literature
Cite
White blood count, D-dimers, and ferritin levels as predictive factors of pulmonary embolism suspected upon admission in noncritically ill COVID-19 patients: The French multicenter CLOTVID retrospective study.
Not available
S-EPMC8239942
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets